Sebastian Havervall

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (10)

Sophia Hober

Professor

KTH Royal Institute of Technology

SWEDEN

View details

Anna Smed Sörensen

Karolinska Institutet

SWEDEN

View details

Anna Månberg (Häggmark)

KTH Royal Institute of Technology

SWEDEN

View details

Maria Jesus Iglesias Mareque

KTH Royal Institute of Technology

SWEDEN

View details

Axel Rosell

Karolinska Institutet

SWEDEN

View details

Max Gordon

Karolinska Institutet

SWEDEN

View details

Jonas Klingstrom

Karolinska Institutet

SWEDEN

View details

Lynn M. Butler

UiT The Arctic University of Norway

NORWAY

View details

Sara Mangsbo

Professor

Uppsala University

SWEDEN

View details

Maguelonne Roux

Institut Pasteur

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sebastian Havervall

Research Interests

Explore related searches

Contact this professor

Articles (11)

Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection

Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines

Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time

Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19

Robust humoral and cellular immune responses and low risk for reinfection at least eight months following asymptomatic to mild COVID-19

An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2

A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies

An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses

COVID-19 is Associated with an Acquired Factor XIII Deficiency

Collaborators (10)

Sophia Hober

Anna Smed Sörensen

Anna Månberg (Häggmark)

Maria Jesus Iglesias Mareque

Axel Rosell

Max Gordon

Jonas Klingstrom

Lynn M. Butler

Sara Mangsbo

Maguelonne Roux

Make your next move.